Lokesh Ravi

According to our database, Lokesh Ravi authored at least 2 papers between 2022 and 2025.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2025

"Heptadecanol" a phytochemical multi-target inhibitor of SMYD3 & GFPT2 proteins in non-small cell lung cancer: an in-silico & in-vitro investigation.

Lokesh Ravi, Pratishtha Jain, Ajith Kumar K, Jeevan Kumar M, Mukti Panda, Harshitha S, Mohammed Abdul Kareem, K. Sivani Yelchuri Sai, Ayman Fathima, V. Jensha, Adarsh Anurag Rai, Hida Amal Faizal, Shrivats S. R, Ankitha Ajith, Derick Yesudas, Vaarruni S, Varshini S, Raksha Shetty, Aditi Jha, Gundlapalli Saradha Janaki, Varsha Hannah George, Stalin Nithaniyal, Mookkandi Palsamy Kesavan, Sajith Ahamed A, Sankara Narayanan A

J. Comput. Aided Mol. Des., December, 2025

2022

Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.

Reji Manjunathan, Vijayalakshmi Periyaswami, Kartik Mitra, Arokiaraj Sherlin Rosita, Medha Pandya, Jayaraman Selvaraj, Lokesh Ravi, Nalini Devarajan, Mukesh Doble

BMC Bioinform., 2022